Content about Treatment of bipolar disorder

WATSONVILLE, Calif. — Nordic Naturals and Lipid Technologies on Tuesday developed a partnership to ensure that practitioners have easy access to the Holman Omega-3 Blood Spot Test for their patients. The Holman Omega-3 Blood Spot Test delivers a fast, easy and accurate measurement of a person’s omega-3 levels, which can aid in making informed choices about diet and supplementation. 

DREXEL HILL, Pa. — The Community Specialty Pharmacy Network has entered a contract with Dara BioSciences to distribute a nonsteroidal anti-estrogen product.

CSPN announced the agreement with Dara to distribute Soltamox (tamoxifen) solution for oral administration. The drug, a treatment for breast cancer, is for patients who have difficulty swallowing pills.

WATSONVILLE, Calif. — Nordic Naturals on Tuesday rolled out a brand new look across its professional product line with a new classification system to better assist selection.

"These labels have been developed with input from professional healthcare practitioners in mind," Nordic Naturals chief medical officer Keri Marshall said. "With more than 40 professional products, our new label design will make dosing and product selection convenient for the practitioner, and ensure the best possible experience for patients."

ROCKVILLE, Md. — The Food and Drug Administration has given tentative approval to Supernus Pharmaceuticals for a drug to treat epilepsy, the company said Tuesday.

Supernus announced the tentative approval was given to Trokendi XR (topiramate), a once-daily treatment for the seizure disorder. The company said final approval was conditioned on resolution of market exclusivity issues concerning certain pediatric populations.

WATSONVILLE, Calif. — Nordic Naturals on Tuesday introduced Algae Omega, a solution for vegetarians seeking the health benefits of marine omega-3s. Made from sustainably sourced microalgae and available in both soft gels and liquid, the product offers an algae-based source of beneficial marine omega-3 essential fatty acids without the use of fish.

"We formulated Algae Omega with vegetarians in mind, and for anyone wanting a readily available, high-quality source of EPA and DHA from a non-fish source," stated Joar Opheim, CEO of Nordic Naturals.

MUMBAI, India — Sun Pharmaceutical Industries has launched a generic version of a drug used to treat psychiatric disorders, the company said.

Sun announced the launch of olanzapine tablets in the 2.5 mg, 5 mg, 7.5 mg, 10 mg, 15 mg and 20 mg strengths.

The drug is a generic version of Eli Lilly's Zyprexa, used to treat schizophrenia and bipolar disorder. The branded drug and generic versions had sales of $3.28 billion during the 12-month period ended in January, according to IMS Health.

PITTSBURGH — Mylan has launched a generic drug for treating psychiatric disorders, the company said Tuesday.

Mylan announced the launch of olanzapine tablets in the 2.5-mg, 5-mg, 7.5-mg, 10-mg, 15-mg and 20-mg strengths.

The drug, a generic version of Eli Lilly's Zyprexa, is used to treat schizophrenia and bipolar disorder. Various versions of the drug had sales of about $3.3 billion in 2011, according to IMS Health.

HYDERABAD, India — Indian drug maker Dr. Reddy's has launched a drug designed to treat bipolar disorder and schizophrenia, the company said.

The company announced the launch of ziprasidone hydrochloride capsules in the 20-mg, 40-mg, 60-mg and 80-mg strengths.

The drug is a generic version of Pfizer's Geodon, which had sales of $1.34 billion in 2011, according to IMS Health.

MOUNTAIN VIEW, Calif. — A Food and Drug Administration panel has voted to recommend approval for a psychiatric drug made by Alexza Pharmaceuticals.

PISCATAWAY, N.J. — A company focused on developing niche generic and specialty pharmaceutical products has received regulatory approval from the Food and Drug Administration for its version of a psychiatric drug.

Innopharma said its abbreviated new drug application for olanzapine injection, a generic equivalent of Zyprexa injection. With this approval, Innopharma announced that it has entered an agreement with Sandoz, who will sell, market and distribute Innopharma's generic in the United States.

CINCINNATI — Prasco Labs will make authorized generic versions of two psychiatric drugs made by Eli Lilly under a partnership between the two companies announced Thursday.

Prasco will market authorized generic versions of Zyprexa (olanzapine) tablets and Zyprexa Zydis orally disintegrating tablets. The drugs are used to treat schizophrenia and bipolar disorder. Financial terms of the deal were not disclosed.

NEW YORK — Anglo-Swedish drug maker AstraZeneca has settled patent infringement lawsuits that it filed against two companies that had sought to market generic versions of one of its drugs.

The company settled with Handa Pharmaceuticals and also with Accord Healthcare and Intas Pharmaceuticals over two generic versions of the bipolar disorder and schizophrenia treatment Seroquel XR (quetiapine fumarate) extended-release tablets.